Hem › Multipelt myelom › Kalifornien › Santa Monica
Kliniska studier för Multipelt myelom i Santa Monica, CA
8 studier för Multipelt myelom söker deltagare vid platser i och runt Santa Monica (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
RekryterarFas 2
- Beverly Hills Cancer Center (BHCC), Beverly Hills · 6 mi bort
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
RekryterarFas 3
- Research Site, Santa Monica
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
RekryterarFas 3
- Beverly Hills Cancer Center Clinical Research Advisors LLC, Beverly Hills · 6 mi bort
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
RekryterarFas 3
- Beverly Hills Cancer Center, Beverly Hills · 6 mi bort
- Clinical Research Advisors (Encino Satellite Location), Encino · 10 mi bort
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
RekryterarFas 3
- Research Site, Santa Monica
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
RekryterarFas 1
- UCLA Health, Jonsson Comprehensive Cancer Center, Santa Monica
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
RekryterarFas 1
- Beverly Hills Cancer Center /ID# 266921, Beverly Hills · 6 mi bort
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
RekryterarFas 3
- GSK Investigational Site, Beverly Hills · 6 mi bort
Multipelt myelom-studier i andra städer
- New York City, NY60 studier
- Boston, MA42 studier
- Atlanta, GA42 studier
- Houston, TX38 studier
- Durham, NC37 studier
- Nashville, TN32 studier
- Denver, CO27 studier
- Rochester, MN24 studier
- St. Louis, MO24 studier
- Columbus, OH24 studier
- Baldwin Park, CA23 studier
- Edison, NJ22 studier
Andra studier i Santa Monica
- Icke-småcellig lungcancer45 studier
- Bröstcancer28 studier
- Kolorektal cancer23 studier
- Cancer (alla typer)22 studier
- Metastaserande cancer19 studier
- Lungcancer15 studier
- Äggstockscancer15 studier
- Prostatacancer15 studier
- Plattenepitelcancer i huvud och hals13 studier
- Hjärtsvikt11 studier
- Endometriecancer10 studier
- Magsäckscancer9 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.